** Shares in Intuitive Surgical ISRG.O down 0.6% ahead of quarterly report due after market close
** The medical device maker is expected to report Q2 adj EPS of $1.92 vs $1.78 year-ago on rev of $2.35 bln vs $2.01 bln in year-ago quarter, according to the latest data from LSEG
** In last 8 quarters ISRG beat the Street's EPS estimate every time while its revenue beat 7 times, with sole miss in Q3 2023
** Q2 will be the first financial report since ISRG leadership reshuffle with its President Dave Rosa promoted to CEO on July 1. In April ISRG said U.S. tariffs would increasingly weigh on its business for rest of the year, disrupting operations in China, potentially eroding competitive edge in contract talks with hospitals.
** Last traded at $512.99 vs median PT of $590, according to LSEG, which shows 33 analyst ratings: 10 'strong buy,' 11 'buy' and 11 'hold' with only 1 'sell' recommendation
** Shares down 1.7% YTD vs 3% fall in S&P 500 healthcare sector .SPXHC
(Reporting by Sinead Carew)
((sinead.carew@thomsonreuters.com))